Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023

幹細胞製造の世界市場予測(~2023年):HSC、MSC、iPSC、ESC、装置、培地、消耗品

◆タイトル:Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023
◆商品コード:BT-6089
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年3月13日
◆ページ数:171
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、幹細胞製造の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、幹細胞製造の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market.
This report broadly segments the stem cell manufacturing market into product, application, end user, and region. On the basis of product, the market is categorized into culture media, consumables, instruments, and stem cell lines. In 2017, the culture media segment accounted for the largest share of the market. The large market share of this segment is attributed the rising stem cell research and increasing demand for stem cell therapies.

Based on application, the market is categorized into three segments, namely, research, clinical, and cell and tissue banking applications. In 2017, cell and tissue banking applications accounted for the largest share of the market. The dominant share of this segment is credited to the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation.

On the basis of end user, the market is segmented into hospitals and surgical centers; pharmaceutical and biotech companies; cell banks and tissue banks; academic institutes, research laboratories, and CROs; and other end users. In 2017, the pharmaceutical and biotech companies accounted for the largest share of the market. The dominant share of this segment is credited to the rising public-private investments for stem cell-based research, ongoing patent expiry of branded drugs, and increasing patient preference for precision & regenerative medicines.

This report covers the market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America accounted for the largest share of the market in 2017. The high intensity of stem cell research in the region, rising public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and rising public awareness on the therapeutic potency of stem cells are driving the growth of the stem cell manufacturing market in North America. However, the Asia Pacific market is projected to register the highest CAGR during the forecast period. The high growth rate in this region can be attributed to the presence/implementation of supportive regulatory frameworks for stem cell research and manufacturing, ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries, and increasing public-private initiatives to encourage public awareness about stem cell-based treatment.

Stem Cell Manufacturing Market

Factor such as significant operational costs associated with stem cell manufacturing & banking is expected to restrain the growth of the market during the forecast period.

The major players in the market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.

【レポートの目次】

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Geographic Scope
1.2.3 Years Considered for the Study
1.3 Currency Used
1.4 Market Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 30)
4.1 Stem Cell Manufacturing: Market Overview (2018)
4.2 Global Stem Cell Manufacturing Market, By Product, 2018
4.3 Market, By Application and Region (2018)
4.4 Market, By End User (2018 vs 2023)
4.5 Geographic Snapshot: Stem Cell Manufacturing Market (2017)

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Public-Private Investments and Funding in Stem Cell-Based Research
5.2.1.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
5.2.1.3 Development of Advanced Genomic Analysis Techniques for Quality Control During Stem Cell Manufacturing
5.2.1.4 Technological Advancements in Stem Cell Manufacturing and Preservation
5.2.1.5 Evolving Regulatory Frameworks for Stem Cell Therapeutics in the US and Europe
5.2.2 Market Restraints
5.2.2.1 Significant Operational Costs Associated With Stem Cell Manufacturing and Banking
5.2.3 Market Opportunities
5.2.3.1 Increased Market Focus on Embryonic Stem Cells (ESCS) and Induced Pluripotent Stem Cells (IPSCS)
5.2.3.2 Supportive Government Regulations Across Developing Countries
5.2.4 Market Challenges
5.2.4.1 Technical Limitations Associated With Manufacturing Scale-Up
5.2.4.2 Socio-Ethical Concerns Related to the Use of Allogenic and Human Embryonic Stem Cells
5.2.5 Research Pipeline Analysis: Stem Cell-Based Products/Therapies

6 Stem Cell Manufacturing Market, By Product (Page No. – 48)
6.1 Introduction
6.2 Stem Cell Lines
6.2.1 Induced Pluripotent Stem Cells
6.2.2 Embryonic Stem Cells
6.2.3 Multipotent Adult Progenitor Stem Cells
6.2.4 Mesenchymal Stem Cells
6.2.5 Hematopoietic Stem Cells
6.2.6 Neural Stem Cells
6.3 Instruments
6.3.1 Bioreactors and Incubators
6.3.2 Cell Sorters
6.3.3 Other Instruments
6.4 Culture Media
6.5 Consumables

7 Stem Cell Manufacturing Market, By Application (Page No. – 62)
7.1 Introduction
7.2 Research Applications
7.2.1 Drug Discovery and Development
7.2.2 Life Science Research
7.3 Clinical Applications
7.3.1 Allogenic Stem Cell Therapy
7.3.2 Autologous Stem Cell Therapy
7.4 Cell and Tissue Banking

8 Stem Cell Manufacturing Market, By End User (Page No. – 72)
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Hospitals and Surgical Centers
8.4 Academic Institutes, Research Laboratories, and Cros
8.5 Cell Banks and Tissue Banks
8.6 Other End Users

9 Stem Cell Manufacturing Market, By Region (Page No. – 79)
9.1 Introduction
9.2 North America
9.2.1 US
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 102)
10.1 Overview
10.2 Market Ranking (2016)
10.3 Competitive Scenario
10.3.1 Product Launches, Upgrades, and Approvals
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Acquisitions
10.3.4 Expansions

11 Company Profiles (Page No. – 107)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Merck Group
11.2 Thermo Fisher Scientific
11.3 Becton, Dickinson and Company (BD)
11.4 Bio-Rad Laboratories
11.5 Miltenyi Biotec
11.6 Pharmicell
11.7 Takara Bio Group
11.8 Stemcell Technologies
11.9 Osiris Therapeutics
11.10 Anterogen
11.11 Cellular Dynamics International (Subsidiary of Fujifilm Holdings Corporation)
11.12 Medipost
11.13 Lonza Group
11.14 Holostem Terapie Avanzate
11.15 Pluristem Therapeutics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 160)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (69 Tables)

Table 1 Key Genome-Based Cell Analysis Products Launched During 2014–2017
Table 2 Global Stem Cell Manufacturing Market, By Product, 2016-2023 (USD Million)
Table 3 Global Market for Stem Cell Lines, By Type, 2016-2023 (USD Million)
Table 4 Market for Stem Cell Lines, By Region, 2016-2023 (USD Million)
Table 5 Key Expansion and Differentiation Technologies to Extract Human-Induced Pluripotent Stem Cell Lines
Table 6 Induced Pluripotent Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 7 Embryonic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 8 Multipotent Adult Progenitor Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 9 Mesenchymal Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 10 Hematopoietic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 11 Neural Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 12 Global Market for Instruments, By Type, 2016-2023 (USD Million)
Table 13 Market for Instruments, By Region, 2016-2023 (USD Million)
Table 14 Market for Bioreactors & Incubators, By Region, 2016-2023 (USD Million)
Table 15 Market for Cell Sorters, By Region, 2016-2023 (USD Million)
Table 16 Market for Other Instruments, By Region, 2016-2023 (USD Million)
Table 17 Market Fort Culture Media, By Region, 2016-2023 (USD Million)
Table 18 Market for Consumables, By Region, 2016-2023 (USD Million)
Table 19 Stem Cell Manufacturing Market, By Application, 2016–2023 (USD Million)
Table 20 Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 21 Stem Cell Manufacturing Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 22 Market for Drug Discovery and Development, By Region, 2016–2023 (USD Million)
Table 23 Market for Life Science Research, By Region, 2016–2023 (USD Million)
Table 24 Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 25 Market for Clinical Applications, By Region, 2016–2023 (USD Million)
Table 26 Market for Allogenic Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 27 Market for Autologous Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 28 Market for Cell & Tissue Banking, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Pharmaceutical and Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 31 Market for Hospitals and Surgical Centers, By Region, 2016–2023 (USD Million)
Table 32 Market for Academic Institutes, Research Laboratories, and Cros, By Region, 2016–2023 (USD Million)
Table 33 Market for Cell Banks and Tissue Banks, By Region, 2016–2023 (USD Million)
Table 34 Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 35 Market, By Region, 2016–2023 (USD Million)
Table 36 North America: Market, By Product, 2016–2023 (USD Million)
Table 37 North America: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 38 North America: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 39 North America: Market, By Application, 2016–2023 (USD Million)
Table 40 North America: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 41 North America: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 42 North America: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Product, 2016–2023 (USD Million)
Table 44 US: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 45 Europe: Market, By Product, 2016–2023 (USD Million)
Table 46 Europe: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 47 Europe: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 48 Europe: Market, By Application, 2016–2023 (USD Million)
Table 49 Europe: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 50 Europe: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 51 Europe: Market, By End User, 2016–2023 (USD Million)
Table 52 Asia Pacific: Stem Cell Manufacturing Market, By Product, 2016–2023 (USD Million)
Table 53 Asia Pacific: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 54 Asia Pacific: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 55 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 56 Asia Pacific: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 57 Asia Pacific: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 58 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 59 RoW: Market, By Product, 2016–2023 (USD Million)
Table 60 RoW: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 61 RoW: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 62 RoW: Market, By Application, 2016–2023 (USD Million)
Table 63 RoW: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 64 RoW: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 65 RoW: Market, By End User, 2016–2023 (USD Million)
Table 66 Key Product Launches, Upgrades, and Approvals, 2014–2017
Table 67 Key Agreements, Partnerships, and Collaborations, 2014–2017
Table 68 Key Acquisitions, 2014–2017
Table 69 Key Expansions, 2014–2017

List of Figures (33 Figures)

Figure 1 Global Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Stem Cell Manufacturing Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During Forecast Period
Figure 7 Research Applications Segment to Dominate the Market During Forecast Period
Figure 8 Cell and Tissue Banks to Be the Fastest-Growing End-User Segment During 2018-2023
Figure 9 Asia Pacific to Grow at the Highest Rate in the Forecast Period
Figure 10 Rising Public-Private Investments and Funding for Stem Cell-Based Research to Drive Market Growth
Figure 11 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 12 North America to Dominate the Market, By Application, in 2018
Figure 13 Cell Banks and Tissue Banks to Be Fastest-Growing Segment During the Forecast Period
Figure 14 North America to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 15 Stem Cell Manufcaturing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Stem Cell Lines to Be the Fastest-Growing Segment During 2018-2023
Figure 17 Stem Cell Manufacturing Market, By Application, 2018 vs 2023
Figure 18 Market, By End User, 2018 vs 2023
Figure 19 Geographic Snapshot: Asia Pacific to Be the Fastest Growing Region in Stem Cell Manufacturing Market During the Forecast Period
Figure 20 North America: Market Snapshot
Figure 21 Europe: Market Snapshot
Figure 22 Asia Pacific: Market Snapshot
Figure 23 RoW: Market Snapshot
Figure 24 Global Market Ranking Analysis, By Key Players (2016)
Figure 25 Merck Group: Company Snapshot (2016)
Figure 26 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 29 Takara Bio Group: Company Snapshot (2017)
Figure 30 Fujifilm Holdings Corporation: Company Snapshot (2017)
Figure 31 Medipost: Company Snapshot (2016)
Figure 32 Lonza Group: Company Snapshot (2016)
Figure 33 Pluristem Therapeutics: Company Snapshot (2016)



【レポートのキーワード】

幹細胞製造、幹細胞培養、HSC、MSC、iPSC、ESC、装置、培地、消耗品

★調査レポート[幹細胞製造の世界市場予測(~2023年):HSC、MSC、iPSC、ESC、装置、培地、消耗品] ( Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023 / BT-6089) 販売に関する免責事項
[幹細胞製造の世界市場予測(~2023年):HSC、MSC、iPSC、ESC、装置、培地、消耗品] ( Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023 / BT-6089) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆